We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Primitive Stem Cells Discovered in Adult Tissue

By Biotechdaily staff writers
Posted on 20 Apr 2006
Scientists have discovered very primitive stem cells in adult tissues that have properties similar to embryonic stem cells and are able to differentiate into most tissues and organs of the body, including spermatogonia.

These early embryonic stem cells appear to be retained in adult tissues as blastomere-like stem cells (BLSCs), according to scientists at Moraga Biotechnology Corp. More...
(Los Angeles, CA, USA), who made the discovery. The new stem cells normally reside in large numbers throughout the body. The company has developed a simple and cost-effective method, using serum-free defined cell culture reagents, for isolating and purifying millions of these stem cells from adult tissue without the need to expand them outside the body.

Moraga scientists reported that they are able to clone these cells into various cell lines from a single cell. They are developing special cell lines and proprietary cell culture media for use by researchers in the life sciences. The company believes these adult-derived stem cells may be an invaluable research tool for discovering new molecular pathways and drugs for treating and possibly curing many forms of cancer in the very near future.

"This recent discovery is a major breakthrough for the company,” said Dr. John Wong, CEO of Moraga. "It makes possible new therapeutic approaches using adult stem cells in the field of regenerative medicine.”

Dr. Wong also observed that the company would quickly enter clinical testing, where damaged tissues--heart, brain, skin, or cartilage--could be repaired with the patient's own unmodified stem cells. The company also plans to use its stem cell technology to treat patients suffering from chronic diseases such as diabetes, Parkinson's disease and Alzheimer's disease, using their own stem cells.


Related Links:
Moraga Biotech

New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
New
Electrolyte Analyzer
BKE-B
New
Immunofluorescence Analyzer
IFA System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.